Description:

PHAR is the ticker symbol for PharamaCyte Biotech Inc., a company listed on the New York Stock Exchange. This biotechnology firm focuses on developing therapies for cancer and diabetes using live cell therapies based on its proprietary Cell-in-a-Box technology. The company aims to provide innovative treatment options by leveraging its unique approach to encapsulating living cells that can be administered to patients, potentially offering new avenues in disease management and treatment. Investors interested in biotech stocks might find PHAR an interesting option due to its focus on cutting-edge research and development in therapeutic areas with significant unmet needs.

Data:

Yields: